Maternal serum markers levels in consecutive pregnancies: A possible genetic predisposition to abnormal levels

American Journal of Medical Genetics

Volumn 61, Issue 2, 1996, Pages 154-157

  Dar, Hanna ^a   Merksamer, Ruth ^a   Berdichevsky, Dolly ^a   David, Miriam ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

AFP; Down syndrome; hCG; NTD; prenatal diagnosis; screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ARTICLE; DOWN SYNDROME; FEMALE; GENETIC PREDISPOSITION; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREGNANCY COMPLICATION; PRENATAL SCREENING; PRIORITY JOURNAL;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; FEMALE; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 0030043056     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960111)61:2<154::AID-AJMG10>3.0.CO;2-T     Document Type: Article

References (12)

1. Baumgarten A (1986): Racial difference and biological significance of maternal serum alpha-fetoprotein. Lancet II:573.
2. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M (1992): The association between unexplained second trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 80:83-86.
3. Gravett CP, Buckmaster JG, Waston PT, Gravett MG (1992): Elevated second trimester maternal serum-HCG concentrations and subsequent adverse pregnancy outcome. Am J Med Gent 44:485-486.
4. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Devereux NS, Bowers GB (1992): Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 327:588-593.
5. Holding S, Cuckle H (1994): Maternal serum screening for Down's syndrome taking account of the result in a previous pregnancy. Prenat Diagn 14:321-324.
6. MacDonald ML, Wagner RM, Slotnick RN (1991): Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol and maternal age. Obstet Gynecol 77: 63-68.
7. Milunsky A (1980): Prenatal detection of neural tube defects VI. Experience with 20,000 pregnancies. J Am Med Assoc 244:2731-2735.
8. Nelson LH, Bensen J, Burton BK (1987): Outcomes in patients with unusually high maternal serum alpha-feto protein levels. Am J Obstet Gynecol 157:572-576.
9. Palomaki GE, Hill LE, Knight GJ, Haddow JE, Carpenter M (1988): Second trimester maternal serum alpha fetoprotein levels in pregnancies with gastroschisis and omphalocele. Obstet Gynecol 71:906-909.
10. Robinson L, Grau P, Crandall BF (1989): Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels. Obstet Gynecol 74:17-20.
11. Wald NJ, Cuckle HS (1981): Raised maternal serum alpha fetoprotein levels in subsequent pregnancies. Lancet 1:1103.
12. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, Knight GJ, Palomaki GE (1988): Maternal serum unconjugated estriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 95:334-341.